Automotive World  Mar 24  Comment 
In January 2017, the Bocholt-based haulage firm Spedition Hillert acquired four MAN TGX 18.460, including the first TGX Efficient Line 3 produced by MAN, and its 500th MAN truck. Three quarters of the MAN branded fleet of vehicles with 96 units...
Automotive World  Jun 17  Comment 
Since 2009 Audi Sport has relied on tractor units from MAN to transport its DTM and LMP racing vehicles to race weekends across Europe. But also spare parts, mobile conference rooms, medical facilities and rooms for engineers are driven along...
Automotive World  May 11  Comment 
The international tire manufacturer Continental is one of the major suppliers for MAN and is strengthening its long-standing partnership with the truck and bus manufacturer. Conti EcoPlus tires from Continental’s Generation 3 truck tires are...
Automotive World  May 6  Comment 
The MAN TGX EfficientLine 2 actively saves on fuel More than 4,600 vehicles and packages sold The MAN TGX EfficientLine 2 combines fuel-saving measures and technologies into a self-contained model without compromises. MAN has sold more than 4,600...
Automotive World  Apr 21  Comment 
Significant cost savings achieved Vortex Logistics, based in Nijmegen in the Netherlands, is updating its fleet with 100 MAN TGX EfficientLine trucks and, in making this change, is demonstrating its focus on environmental concerns.Vortex...
Automotive World  Dec 4  Comment 
350 TGX Euro 6 trucks ordered, first deliveries already made The Austrian logistics specialist Quehenberger has placed an order for 350 of the new 440 hp and 480 hp MAN TGX semitrailer tractors. Based in Straßwalchen near Salzburg, the company is...
Automotive World  Sep 26  Comment 
Major potential for CO2 savings in long-distance transport Hybrid drives in commercial vehicles will be part of the drive concept of the future in all areas of application. However, different hybrid concepts are required in light of the very...
Automotive World  Sep 23  Comment 
Potential for synergies in Volkswagen Group MAN and Scania will be cooperating on vehicle gearboxes in the future. As part of this collaboration, from 2016 Scania’s gearbox hardware will be gradually implemented in TGS and TGX series MAN...
Automotive World  Aug 8  Comment 
As the second largest exhibitor at the IAA, MAN Truck and Bus presents new vehicle and engine technologies, with the top-of-the-range TGX D38 truck with up to 640 HP as its centrepiece. We are delighted to invite you to our press conference on 24...
TheStreet.com  Feb 24  Comment 
NEW YORK (The Deal) -- J. Travis Laster is a bold judge, and the Delaware vice chancellor was at his most aggressive in a Feb. 21 order where he asked very probing questions of the shareholders and lawyers who brought a fiduciary duty lawsuit...


Theragenics s a medical device company serving the surgical products and cancer treatment markets. The company makes money by manufacturing, marketing and selling disposable devices primarily used in certain surgical procedures.[1] The company also makes money by producing wound closure, vascular access and specialty needles. Most importantly for its profitability, Theragenics is highly dependent on reimbursement rates and favorable treatment from healthcare providers such as Medicare.

Business Growth

Critical to Theragenics' growth is acquisition prospects to diversify its revenue stream as well as provide opportunities with synergies through combining product lines and intellectual property. Despite the possibility of potentially dilutive acquisitions, the company believes that long-term wise, acquisitions diversify existing product offerings, augment market coverage and customer base, enhance technological capabilities or offer revenue and profit growth opportunities.[2]

Trends and Forces

TGX Operates in an Industry that is Highly Dependent Upon a Few Major Customers

Because there are more than one type of treatments for medical conditions, the product placements for the same type of condition is not identical. For example, in Theragenics' seed business, alternative competing treatments are MRT and robotic surgery, which all have been gaining market share.[3] This gain in market share is determinant upon favorable reimbursement rates set by Medicare, and therefore the industry is very much dependent upon treatment by these larger entities. Should Medicare favor certain larger companies over smaller entities such as Theragenics, because larger companies may respond quicker to new or emerging technologies and changes in customer requirements.

TGX Must Constantly Face Technological Change to Keep Ahead of Competition

TGX operates in an industry where rapid and significant technology change in products offered is the key to staying ahead of an evolving industry. TGX constantly invests in new brachytherapy, wound closure, vascular access, and specialty needle products. However, many of these brachytherapy and surgical products are technologically innovative and require significant planning, design, development and testing. These activities require significant capital commitments and investment. The securing of capital is therefore crucial to continuously stay competitively advantageous in the marketplace.


TGX competes in a wide scope of medical applications that compete for relatively few entities as customers such as Medicare.

  • C.R. Bard (BCR) is engaged in the design, manufacture, packaging, distribution and sale of medical, surgical, diagnostic and patient care devices.[4]
  • Merit Medical Systems (MMSI) designs, develops, manufactures and markets single-use medical products for interventional and diagnostic procedures.[5]
  • Medtronic (MDT) manufactures and sells device-based medical therapies.


  1. TGX FY2010 10-K, Pg 1
  2. TGX FY2010 10-K, Pg 10
  3. TGX FY2010 10-K, Pg 21
  4. BCR Business Description
  5. MMSI Business Description
Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki